Li, X., Yuan, Hf., Quan, Qk. et al. Scavenging effect of Naoerkang (脑尔康) on amyloid beta-peptide deposition in the hippocampus in a rat model of Alzheimer’s disease., Chin. J. Integr. Med. 17, 847–853 (2011). https://doi.org/10.1007/s11655-011-0896-7
Xi Li, Hai-feng Yuan, Qian-kun Quan, et al. Scavenging effect of Naoerkang (脑尔康) on amyloid beta-peptide deposition in the hippocampus in a rat model of Alzheimer’s disease[J]. Chinese Journal of Integrative Medicine, 2011,17(11):847-853.
Li, X., Yuan, Hf., Quan, Qk. et al. Scavenging effect of Naoerkang (脑尔康) on amyloid beta-peptide deposition in the hippocampus in a rat model of Alzheimer’s disease., Chin. J. Integr. Med. 17, 847–853 (2011). https://doi.org/10.1007/s11655-011-0896-7DOI:
Xi Li, Hai-feng Yuan, Qian-kun Quan, et al. Scavenging effect of Naoerkang (脑尔康) on amyloid beta-peptide deposition in the hippocampus in a rat model of Alzheimer’s disease[J]. Chinese Journal of Integrative Medicine, 2011,17(11):847-853. DOI: 10.1007/s11655-011-0896-7.
Scavenging effect of Naoerkang (脑尔康) on amyloid beta-peptide deposition in the hippocampus in a rat model of Alzheimer’s disease
摘要
To observe the effect of a Chinese medicine compound
Naoerkang (脑尔康
NEK)
on amyloid-beta peptide (1–42; Aβ1–42) and matrix metalloproteinase-9 (MMP-9) expressions in the hippocampus of Alzheimer’s disease (AD) model rats. A total of 48 male Sprague Dawley (SD) rats were randomly divided into normal control
untreated
and piracetam groups
and low-dose
medium-dose
and high-dose NEK groups
with 8 rats in each group. The 5-μL aggregated Aβ1–42 (2 μg/μL) were injected into both CA1 areas of the hippocampus in the rats to establish an AD model
whereas the normal control was treated with the same dose of normal saline. The rats in the NEK groups were treated with a high
medium
or low dose of NEK [60 g/(kg·d)
30 g/(kg·d)
and 15 g/(kg·d)]
respectively
intragastrically for 28 days; piracetam (0.375 g/kg
intragastrically) was consecutively administered in the piracetam group; and normal saline was applied in the normal control and untreated groups. A Y-maze test was used for behavioral study to test the learning and memory abilities. Aβ1–42 and MMP-9 expressions in the hippocampus was determined immunohistochemically
and the results were analyzed by image acquisition and an analysis system. Aggregated Aβ1–42 induced obvious learning and memory dysfunction
as well as up-regulation of Aβ1–42 expression in the hippocampus. Compared with those in the normal control group
the learning and memory abilities of rats in the untreated group significantly decreased (P<0.01)
and the expression of Aβ1–42 was significantly increased (P<0.01). Twenty-eight days after different treatments
compared with those in the untreated group
the learning and memory abilities of AD model rats in the piracetam
low-dose
medium-dose and high-dose NEK groups were significantly improved (P<0.01 or P<0.05)
and the expression of Aβ1–42 in the hippocampus decreased (P<0.01 or P<0.05)
and MMP-9 increased (P<0.01 or P<0.05)
especially in the high-dose NEK group. NEK might play a role of anti-dementia by increasing the expression of MMP-9 in the hippocampus of AD model rats
resulting in the reduction of the quantity of Aβ1–42 and improvement in learning and memory ability in AD model rats.
Abstract
To observe the effect of a Chinese medicine compound
Naoerkang (脑尔康
NEK)
on amyloid-beta peptide (1–42; Aβ1–42) and matrix metalloproteinase-9 (MMP-9) expressions in the hippocampus of Alzheimer’s disease (AD) model rats. A total of 48 male Sprague Dawley (SD) rats were randomly divided into normal control
untreated
and piracetam groups
and low-dose
medium-dose
and high-dose NEK groups
with 8 rats in each group. The 5-μL aggregated Aβ1–42 (2 μg/μL) were injected into both CA1 areas of the hippocampus in the rats to establish an AD model
whereas the normal control was treated with the same dose of normal saline. The rats in the NEK groups were treated with a high
medium
or low dose of NEK [60 g/(kg·d)
30 g/(kg·d)
and 15 g/(kg·d)]
respectively
intragastrically for 28 days; piracetam (0.375 g/kg
intragastrically) was consecutively administered in the piracetam group; and normal saline was applied in the normal control and untreated groups. A Y-maze test was used for behavioral study to test the learning and memory abilities. Aβ1–42 and MMP-9 expressions in the hippocampus was determined immunohistochemically
and the results were analyzed by image acquisition and an analysis system. Aggregated Aβ1–42 induced obvious learning and memory dysfunction
as well as up-regulation of Aβ1–42 expression in the hippocampus. Compared with those in the normal control group
the learning and memory abilities of rats in the untreated group significantly decreased (P<0.01)
and the expression of Aβ1–42 was significantly increased (P<0.01). Twenty-eight days after different treatments
compared with those in the untreated group
the learning and memory abilities of AD model rats in the piracetam
low-dose
medium-dose and high-dose NEK groups were significantly improved (P<0.01 or P<0.05)
and the expression of Aβ1–42 in the hippocampus decreased (P<0.01 or P<0.05)
and MMP-9 increased (P<0.01 or P<0.05)
especially in the high-dose NEK group. NEK might play a role of anti-dementia by increasing the expression of MMP-9 in the hippocampus of AD model rats
resulting in the reduction of the quantity of Aβ1–42 and improvement in learning and memory ability in AD model rats.
Gallardo G, Schlüter OM, Südhof TC. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides. Nat Neurosci 2008;11:301–308.
Huang RX, Liang XL, Liu ZL. Clinical neurology. Beijing: People’s Medical Publishing House; 1998:505–506.
Yan P, Hu X, Song H, Yin K, Bateman RJ, Cirrito JR, et al. Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ. J Biol Chem 2006;281:24566–24574.
Li X, Zhang XF, Qiao CL, Zhang ZY. Influence of Naoerkang on the intracerebral cholinesterase activity and neurons of mice with Alzheimer’s disease. Chin J Clin Rehabil (Chin) 2003;7:4222–4223.
Li X, Wang JJ, Qiao CL, Nie DL. Effects of Naoerkang on learning and memory dysfunction in mouse. J Xi’an Jiaotong Univ (Med Sci, Chin) 1999;20:126–127.
Bao XM, Shu SY. The rat brain in stereotaxic coordinates. Beijing: People’s Medical Publishing House; 1990:42.
Tian JZ, Xu Y, Shi J, Yin JX, Ji ZJ, Zhao ZW, et al. Effect of GETO extract on expression of growth-associated protein 43 in area CA1 of hippocampus in Alzheimer’s disease model rats induced by Aβ42 peptide. Chin J Integr Med Cardio-/Cerebrovas Dis (Chin) 2007;5:217–219.
Li QM, Meng RS, Wei CX, Kan FJ, Huang QH. Effects of Naohuandan recipe on learning and memory abilities of SAM-P/8 mice and its role in anti-oxidation and antiapoptosis. J Chin Integr Med (Chin) 2006;4:48–51.
Du GH. Experimental pharmacology. Beijing: Peking Union Medical College Press; 2004:33.
Yang P. Beta-amyloid peptide and Alzheimer’s disease. Med Recaptulate (Chin) 2001;7: 604–605.
Tanzi RE, Moir RD, Wagner SL. Clearance of Alzheimer’s A beta peptide: the many roads to perdition. Neuron 2004;43:605–608.
Yong VW, Krekoski CA, Forsyth PA, Bell R, Edwards DR. Matrix metalloproteinases and diseases of the CNS. Trends Neurosci 1998;21:75–80.
Van den Steen PE, Dubois B, Nelissen I, Rudd PM, Dwek RA, Opdenakker G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol 2002;37:375–536.
Zhang JT. Nootropic mechanisms of ginsenoside Rg1-influence on neuronal plasticity and neurogenesis. Acta Pharm Sin (Chin) 2005;40:385–388.
Wang WX, Wang W, Chen KJ. Protective effect and mechanism of ginsenosides on central nerve system of animals. Chin J Integr Tradit West Med (Chin) 2005;25:89–93.
Shi RR, He LM, Hu YE, Weng SW, Cao YR, Yi NY. Regulation of milkvetch root on M-cholinergic receptors in the aged rats. J Tradit Chin Med (Chin) 1998;39:685–686.
Ji ZH, Yu XY, Zhang XL, Han H, Zhang W, Wang YF. Interventional effect of the water extract of Alpinia oxyphylla Miq. fruit on scopolamine-induced learning and memory impairements in rats. Chin J Clin Rehabi (Chin) 2005;8:120–122.
Yu ZL, Zhang GQ, Zhao HQ, Lu JF. Effect of puerariae isoflavone on memory in mice. J China Pharm Univ (Chin) 1997;28:350–353.
Zhang C, Wang SZ, Zuo PP, Cui X, Cai J. Effect of tetramethylpyrazine on learning,memory and cholinergic system in D-galactose-lesioned mice. Chin Acta Academiae Med Sinicae (Chin) 2003;25:553–556.
Cheng YM, Wang NY. Effect of borneol on the intercellular tight junction and pinocytosis vesicles in vitro bloodbrain barrier model. Chin J Integr Tradit West Med (Chin) 2004;24:632–634.
Effects of Fengbaisan (丰白散) on the expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in lung tissue of rats with chronic obstructive pulmonary disease
Effect of acupuncture on proliferation and differentiation of neural stem cells in brain tissues of rats with traumatic brain injury
The effect of Chaiqin Chengqi Decoction (柴芩承气汤) on modulating serum matrix metalloproteinase 9 in patients with severe acute pancreatitis
Effect of Huannao Yicong Prescription (还脑益聪方) extract on β-Amyloid precursor protein metabolic signal transduction-related protein in brain tissue of dementia model transgenic mouse
Effects of Fufang Shenhua Tablet (复方肾华片) on the expression of toll-like receptors during acute kidney injury induced by ischemia-reperfusion in rats
相关作者
暂无数据
相关机构
Institute of Integrated Traditional Chinese and Western Medicine, Xiangya Hospital, Central South University
Department of Traditional Chinese Medicine, the 2nd Xiangya Hospital, Central South University
Guangzhou University of Traditional Chinese Medicine
Jinan University
Department of General Surgery, West China Hospital, Sichuan University